Envato sold for $373M | Ozempic's bulging prices | Will Sony take over Paramount Global?

Envato, the Australian tech company, has been sold for over $370 million, in one of the largest tech exits in Australian history. Novo Nordisk, the pharmaceutical company behind diabetes slash weight loss drug Ozempic, drops price amidst competition. Media giant Paramount Global is in talks with Sony over a potential buyout that could be worth $39 billion…after a failed negotiation with another potential buyer. —Build the financial wellbeing of your team with Flux at Work: https://bit.ly/fluxatworkDownload the free app (App Store): http://bit.ly/FluxAppStoreDownload the free app (Google Play): http://bit.ly/FluxappGooglePlayDaily newsletter: https://bit.ly/fluxnewsletterFlux on Instagram: http://bit.ly/fluxinstaFlux on TikTok: https://www.tiktok.com/@flux.finance—-The content in this podcast reflects the views and opinions of the hosts, and is intended for personal and not commercial use. We do not represent or endorse the accuracy or reliability of any opinion, statement or other information provided or distributed in these episodes.See omnystudio.com/listener for privacy information.